1. Extranodal Lymphoma of the Breast
- Author
-
Brandi T. Nicholson, Rahat M. Bhatti, and Leonard Glassman
- Subjects
medicine.medical_specialty ,Lymphoma ,medicine.medical_treatment ,030218 nuclear medicine & medical imaging ,Diagnosis, Differential ,03 medical and health sciences ,Primary Breast Lymphoma ,0302 clinical medicine ,Breast cancer ,immune system diseases ,hemic and lymphatic diseases ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,skin and connective tissue diseases ,B-cell lymphoma ,Chemotherapy ,Evidence-Based Medicine ,Palpation ,business.industry ,Imaging study ,Chemoradiotherapy ,General Medicine ,medicine.disease ,030220 oncology & carcinogenesis ,Needle biopsy ,Extranodal lymphoma ,Female ,Radiology ,business ,Mammography - Abstract
Extranodal lymphoma represents fewer than 0.5% of all breast malignancies. Secondary involvement of the breast with lymphoma is more common than primary breast lymphoma. The most common primary breast lymphoma is B-cell lymphoma. The initial imaging study of choice for a woman with a new breast mass is a diagnostic mammogram. In younger women ultrasound is more commonly the first imaging modality performed. Diagnosis is made from image-guided or physical examination-directed needle biopsy. Treatment is different from that for breast cancer, in that surgery is not the mainstay. Patients with breast lymphoma are treated primarily with chemotherapy and radiation.
- Published
- 2016